home.aspx
 
EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...

B. McLaughlin Associates, Inc (BMA)

SHARESHARESHARE
BMA is a niche CRO that has been providing functional support in the areas of Data Management and Study Management for over 20 years. Our unique size, coupled with extensive therapeutic experience, allow us to consistently provide personalized, flexible services, and help clients reach critical clinical trial goals and timelines.
SHARESHARESHARE

RELATED NEWS


A new report has found that there are more than 2,000 immunotherapy drugs now in development for cancer, with 940 of these in clinical stage development and 1,064 at the preclinical stage. The report, “Comprehensive Analysis of the Immuno-Oncology Landscape” by the Cancer Research Institute (CRI), is a first-of-its-kind independent analysis of the global immuno-oncology landscape, from agents in pre-clinical development to regulatory approval. The report says that the significant num...

READ MORE

The Zur Rose Group is nominating Tobias Hartmann, Dr. Christian Mielsch and Florian Seubert as new members of the Board of Directors and proposing them for election at the General Meeting of Shareholders to be held on 23 May 2019. The nomination is intended to add proven expertise in technology, trading and finance to the company's highest board.As  part of the positioning of the Zur Rose Group as a comprehensive, integrated healthcare platform and its associated further development as ...
PHARMIWEB
READ MORE

New research reveals for the first time that diverse drugs that induce general anesthesia activate a brain circuit that brings on sleep. The scientists at Duke University in Durham, NC who carried out the study, suggest that the findings will help to develop better drugs that can induce sleep with fewer adverse reactions. Since 1846, when a dentist and a surgeoncarried out the first successful surgical procedure to use anesthesia, a number of general anesthetic drugs have emerged. Yet, until the...

READ MORE

Oxford Biomedica and Santen have announced plans to enter into a research and development collaboration and option and licence agreement for development of gene therapy vectors for inherited retinal disease. The aim of the collaboration is to generate pre-clinical proof of concept to treat an inherited retinal disease with lentiviral vectors developed and manufactured by Oxford Biomedica, and includes a licence to use the company’s LentiVector platform. John Dawson, chief executive officer...

READ MORE

Indian drugmaker Cadila Healthcare said a recent FDA inspection of its topical manufacturing facility at Changodar, Ahmedabad, resulted in no observations from the regulatory agency. The inspection was conducted from March 22 through Wednesday. Of the 10 ANDA approvals the company has received from the FDA between 2016 and 2017, one was its first topical product approval for the formulations plant located in Ahmedabad. In late 2016, the company’s Moraiya plant, which is a formulation site,...
FIERCEPHARMA
READ MORE

First launched as a PC game in 2015, Big Pharma will be available for all three major games consoles – Sony’s PlayStation 4, Nintendo Switch, and Microsoft Xbox One – from next month, according to publisher Klabater. The game – developed by Twice Circled and Positech Games – is described as “part business sim, part logistics puzzle,” and puts players in the hot seat of a biopharma start-up, trying to translate R&D discoveries into blockbuster brands ...

READ MORE

EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...